Abstract
A number of small cell-permeant protein kinase inhibitors have been developed that have the potential for treating a variety of diseases. The basis for the specificity of several of these drugs has been elucidated and a number are undergoing human clinical trials.
| Original language | English |
|---|---|
| Pages (from-to) | 459-465 |
| Number of pages | 7 |
| Journal | Current Opinion in Chemical Biology |
| Volume | 3 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 1999 |
| Externally published | Yes |